What Is the Role of HSCT in Philadelphia-Chromosome–Positive and Philadelphia-Chromosome–Like ALL in the Tyrosine Kinase Inhibitor Era?

Previously, the outcome of paediatric Philadelphia-chromosome–positive (Ph(+)) ALL treated with conventional chemotherapy alone was poor, necessitating the use of haematopoietic stem cell transplantation (HSCT) for the best outcomes. The recent addition of tyrosine kinase inhibitors (TKIs) alongside...

Descripción completa

Detalles Bibliográficos
Autores principales: Vettenranta, Kim, Dobsinska, Veronika, Kertész, Gabriella, Svec, Peter, Buechner, Jochen, Schultz, Kirk R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848997/
https://www.ncbi.nlm.nih.gov/pubmed/35186828
http://dx.doi.org/10.3389/fped.2021.807002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848997/
https://www.ncbi.nlm.nih.gov/pubmed/35186828
http://dx.doi.org/10.3389/fped.2021.807002

Ejemplares similares